Benfenati, Fabio http://orcid.org/0000-0002-0653-8368
Lanzani, Guglielmo http://orcid.org/0000-0002-2442-4495
Article History
Received: 3 January 2021
Accepted: 19 October 2021
First Online: 9 December 2021
Competing interests
: G.L. and F.B. are consultants of Novavido Srl, a company that develops organic retinal prostheses. The P3HT-NP technology is the subject of US patent application US 16/005,248 ‘Eye-injectable polymeric nanoparticles and method of use therefor’ by Istituto Italiano di Tecnologia and Ospedale Sacrocuore Don Calabria, which is licensed to Novavido Srl.